Pharmaceutical Industry

Investment Biotechnology Drug Development Corporate Strategy Competition Perrigo Co Rare Diseases Drugs Rare Disease Drugs AI in Drug Development Eli Lilly Regulatory Approval Cancer Treatment Cancer Treatments Biotech Companies Recent Acquisitions Orchard Therapeutics Acquisition Ophthalmology Genetic Research Genetic Testing Genomics Vaccine Development Obesity Drugs Startup Companies Deal Making Market Competition Corporate Acquisitions Retail Pharmacy Immunology Radiopharmaceuticals

6 ARTICLES

3w ago

Telix to Acquire German Isotope Maker ITM in Up to $2.35 Billion Deal

The transaction is intended to lock in supplies of lutetium-177, actinium-225 and terbium-161, speed commercial rollout, with up to $700 million in payments tied to regulatory approvals and sales milestones.

8 ARTICLES

last mo.

Lilly to Buy Merida Biosciences for Up to $2.875 Billion

11 ARTICLES

2mo ago

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

5 ARTICLES

7mo ago

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

8 ARTICLES

8mo ago

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

4 ARTICLES

8mo ago

Lilly Strikes Up to $1.12 Billion Pact With Seamless Therapeutics for Hearing‑Loss Gene Editing

8 ARTICLES

10mo ago

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

5 ARTICLES

10mo ago

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

8 ARTICLES

11mo ago

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

4 ARTICLES

last yr.

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

50 ARTICLES

last yr.

Regeneron to Acquire 23andMe for $256 Million Following Bankruptcy Auction